KR100762945B1 - 동물 세포주를 이용한 이듀로네이트-설파타제의 발현 방법및 그 발현을 위한 세포주 - Google Patents
동물 세포주를 이용한 이듀로네이트-설파타제의 발현 방법및 그 발현을 위한 세포주 Download PDFInfo
- Publication number
- KR100762945B1 KR100762945B1 KR1020040071531A KR20040071531A KR100762945B1 KR 100762945 B1 KR100762945 B1 KR 100762945B1 KR 1020040071531 A KR1020040071531 A KR 1020040071531A KR 20040071531 A KR20040071531 A KR 20040071531A KR 100762945 B1 KR100762945 B1 KR 100762945B1
- Authority
- KR
- South Korea
- Prior art keywords
- ids
- expression
- cell line
- sulfatase
- cho cell
- Prior art date
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0681—Cells of the genital tract; Non-germinal cells from gonads
- C12N5/0682—Cells of the female genital tract, e.g. endometrium; Non-germinal cells from ovaries, e.g. ovarian follicle cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2511/00—Cells for large scale production
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/06—Sulfuric ester hydrolases (3.1.6)
- C12Y301/06013—Iduronate-2-sulfatase (3.1.6.13)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Reproductive Health (AREA)
- Cell Biology (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
본 발명에서 이루고자 하는 기술적 과제는 뮤코다당증의 치료제 또는 경감제로서 이듀로네이트-2-설파타제를 생물학적 방법으로 생산하는 방법을 발명한 것으로, 이러한 생물학적 방법 및 이에 사용되는 형질전환 CHO 세포주를 제공하는 것이다.
본 발명의 효과는 뮤코다당증의 치료제 또는 경감제로서 이듀로네이트-2-설파타제를 생물학적 방법으로 생산하는 방법을 발명한 것으로, 이러한 생물학적 방 법 및 이에 사용되는 형질전환 CHO 세포주를 제공하는 것이다.
Claims (3)
- 삭제
- 삭제
- 비코딩 구역, 리더 서열 및 서열번호: 1의 이듀로네이트-2-설파타제 코딩 서열을 삽입시킨 형질전환 벡터(7.2 kb)를 세포 내 염색체에 인티그레이션시킨 형질전환 CHO 세포주에 있어서, 상기 형질전환 CHO 세포주는 1 μM MTX 농도에서 흡광도 분석을 통해 0.4 x 106 세포수/일 이상으로 생장함을 특징으로 하는 이듀로네이트-2-설파타제 과발현 형질전환 CHO 세포주 (기탁번호 KCTC 10685BP호)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020040071531A KR100762945B1 (ko) | 2004-09-08 | 2004-09-08 | 동물 세포주를 이용한 이듀로네이트-설파타제의 발현 방법및 그 발현을 위한 세포주 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020040071531A KR100762945B1 (ko) | 2004-09-08 | 2004-09-08 | 동물 세포주를 이용한 이듀로네이트-설파타제의 발현 방법및 그 발현을 위한 세포주 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20040084881A KR20040084881A (ko) | 2004-10-06 |
KR100762945B1 true KR100762945B1 (ko) | 2007-10-04 |
Family
ID=37368186
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020040071531A KR100762945B1 (ko) | 2004-09-08 | 2004-09-08 | 동물 세포주를 이용한 이듀로네이트-설파타제의 발현 방법및 그 발현을 위한 세포주 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100762945B1 (ko) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT202200007808A1 (it) | 2022-04-20 | 2023-10-20 | Luigi Michele Pavone | Composizioni terapeutiche per malattie causate da accumulo di eparan solfato |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3101125A1 (en) * | 2015-06-05 | 2016-12-07 | Laboratorios Del Dr. Esteve, S.A. | Adenoassociated virus vectors for the treatment of mucopolysaccharidoses |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR19990073788A (ko) * | 1998-03-03 | 1999-10-05 | 진동규 | 헌터 증후군의 유전자 요법에 사용될 수 있는 레트로바이러스벡터 |
US6541254B1 (en) | 1991-11-12 | 2003-04-01 | Women's And Children's Hospital | Glycosylation variants of iduronate 2-sulfatase |
-
2004
- 2004-09-08 KR KR1020040071531A patent/KR100762945B1/ko active IP Right Grant
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6541254B1 (en) | 1991-11-12 | 2003-04-01 | Women's And Children's Hospital | Glycosylation variants of iduronate 2-sulfatase |
KR19990073788A (ko) * | 1998-03-03 | 1999-10-05 | 진동규 | 헌터 증후군의 유전자 요법에 사용될 수 있는 레트로바이러스벡터 |
Non-Patent Citations (1)
Title |
---|
GenBank Accession No. M58342 Human iduronate 2-sulfatase (1995.03.07. 공개) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT202200007808A1 (it) | 2022-04-20 | 2023-10-20 | Luigi Michele Pavone | Composizioni terapeutiche per malattie causate da accumulo di eparan solfato |
WO2023203004A1 (en) | 2022-04-20 | 2023-10-26 | Pavone Luigi Michele | Therapeutic compositions with imino sugars for the treatment of diseases with accumulation of heparan sulfate |
Also Published As
Publication number | Publication date |
---|---|
KR20040084881A (ko) | 2004-10-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Mattsson et al. | Molecular and immunological characterization of Can f 4: a dog dander allergen cross‐reactive with a 23 kDa odorant‐binding protein in cow dander | |
TWI523946B (zh) | 位置特異性整合 | |
BR112014005816A2 (pt) | endoglicosidase de streptococcus pyogenes e métodos de uso | |
CN108265056B (zh) | 一种重组户尘螨1类变应原蛋白及其制备方法和应用 | |
MXPA01012665A (es) | El promotor genetico de la miostatina e inhibicion de la activacion del mismo. | |
CN112920275B (zh) | 可特异性结合sST2的结合蛋白、试剂和试剂盒 | |
AU743300B2 (en) | Proteome analysis for characterization of up- and down-regulated proteins in biological samples | |
EA007813B1 (ru) | Секретируемый белок | |
KR100762945B1 (ko) | 동물 세포주를 이용한 이듀로네이트-설파타제의 발현 방법및 그 발현을 위한 세포주 | |
WO2004018633A2 (en) | Abca13 nucleic acids and proteins, and uses thereof | |
CN105601750B (zh) | 一种基因重组人c肽融合蛋白及其制备方法与应用 | |
CN112512310B (zh) | 用于无糖基化抗体产生的转基因小鼠和由此产生的无糖基化抗体的用途 | |
Collombet et al. | Eukaryotic DING proteins are endogenous: an immunohistological study in mouse tissues | |
Sohn et al. | Enhanced sialylation and in vivo efficacy of recombinant human α-galactosidase through in vitro glycosylation | |
KR101962865B1 (ko) | 생체 스트레스 진단용 항원의 제조방법, 생체 스트레스 진단용 항체의 제조방법, 생체 스트레스 진단용 조성물 및 진단용 키트 | |
CN109810196B (zh) | 一种水稻Cu/Zn-SOD多克隆抗体的制备方法和应用 | |
EP2282768B1 (en) | Anti-hmga1 monoclonal antibodies, process for their preparation and their use for the quantitative determination of hmga1 | |
JP4315257B2 (ja) | 新規コンドロイチン硫酸プロテオグリカン、そのコア蛋白質、それをコードするdnaおよびそれに対する抗体 | |
KR20070109347A (ko) | 인간 ctrp1을 특이적으로 인식하는 단일클론 항체 및이를 생산하는 하이브리도마 세포 | |
JP5719504B2 (ja) | カスパーゼ−14特異的モノクローナル抗体 | |
US20070087983A1 (en) | Novel ubp8rp polypeptides and their use in the treatment of psoriasis | |
CN114516916A (zh) | 一种抗gpr65的单克隆抗体、分泌该抗体的杂交瘤细胞株及应用 | |
JP5029751B2 (ja) | 組換えイヌプロラクチンおよびその製造方法 | |
JP4198248B2 (ja) | 糖化型bpgmアッセイ | |
CN116813742A (zh) | 人gdf-15抗原表位肽、抗原、抗体、试剂盒及应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E90F | Notification of reason for final refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
G170 | Publication of correction | ||
FPAY | Annual fee payment |
Payment date: 20130531 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20140618 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20150710 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20160629 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20170712 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20180712 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20190718 Year of fee payment: 13 |